JP2008538779A5 - - Google Patents

Download PDF

Info

Publication number
JP2008538779A5
JP2008538779A5 JP2008508135A JP2008508135A JP2008538779A5 JP 2008538779 A5 JP2008538779 A5 JP 2008538779A5 JP 2008508135 A JP2008508135 A JP 2008508135A JP 2008508135 A JP2008508135 A JP 2008508135A JP 2008538779 A5 JP2008538779 A5 JP 2008538779A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
compound
unsubstituted
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008508135A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008538779A (ja
Filing date
Publication date
Priority claimed from GBGB0508314.2A external-priority patent/GB0508314D0/en
Application filed filed Critical
Publication of JP2008538779A publication Critical patent/JP2008538779A/ja
Publication of JP2008538779A5 publication Critical patent/JP2008538779A5/ja
Pending legal-status Critical Current

Links

JP2008508135A 2005-04-25 2006-04-24 アセチレン誘導体 Pending JP2008538779A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0508314.2A GB0508314D0 (en) 2005-04-25 2005-04-25 Organic compounds
PCT/EP2006/003768 WO2006114264A1 (en) 2005-04-25 2006-04-24 Acetylene derivatives

Publications (2)

Publication Number Publication Date
JP2008538779A JP2008538779A (ja) 2008-11-06
JP2008538779A5 true JP2008538779A5 (cg-RX-API-DMAC7.html) 2009-07-02

Family

ID=34640064

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008508135A Pending JP2008538779A (ja) 2005-04-25 2006-04-24 アセチレン誘導体

Country Status (17)

Country Link
US (1) US20080194551A1 (cg-RX-API-DMAC7.html)
EP (1) EP1877367B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008538779A (cg-RX-API-DMAC7.html)
KR (1) KR20080007334A (cg-RX-API-DMAC7.html)
CN (1) CN101163669A (cg-RX-API-DMAC7.html)
AT (1) ATE445593T1 (cg-RX-API-DMAC7.html)
AU (1) AU2006239549A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0609945A2 (cg-RX-API-DMAC7.html)
CA (1) CA2605267A1 (cg-RX-API-DMAC7.html)
DE (1) DE602006009789D1 (cg-RX-API-DMAC7.html)
ES (1) ES2335134T3 (cg-RX-API-DMAC7.html)
GB (1) GB0508314D0 (cg-RX-API-DMAC7.html)
MX (1) MX2007013226A (cg-RX-API-DMAC7.html)
PL (1) PL1877367T3 (cg-RX-API-DMAC7.html)
PT (1) PT1877367E (cg-RX-API-DMAC7.html)
RU (1) RU2007143509A (cg-RX-API-DMAC7.html)
WO (1) WO2006114264A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0220581D0 (en) 2002-09-04 2002-10-09 Novartis Ag Organic Compound
PE20060437A1 (es) * 2004-06-18 2006-06-08 Novartis Ag COMPUESTOS AZA-BICICLONONANOS COMO LIGANDOS COLINERGICOS DE nAChR
GB0415746D0 (en) 2004-07-14 2004-08-18 Novartis Ag Organic compounds
GB0503646D0 (en) * 2005-02-22 2005-03-30 Novartis Ag Organic compounds
GB0508318D0 (en) * 2005-04-25 2005-06-01 Novartis Ag Organic compounds
GB0508319D0 (en) * 2005-04-25 2005-06-01 Novartis Ag Organic compounds
GB0525673D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
GB0525672D0 (en) 2005-12-16 2006-01-25 Novartis Ag Organic compounds
US8349852B2 (en) 2009-01-13 2013-01-08 Novartis Ag Quinazolinone derivatives useful as vanilloid antagonists
AR080056A1 (es) 2010-02-01 2012-03-07 Novartis Ag Derivados de ciclohexil-amida como antagonistas de los receptores de crf
JP2013518085A (ja) 2010-02-01 2013-05-20 ノバルティス アーゲー CRF−1受容体アンタゴニストとしてのピラゾロ[5,1b]オキサゾール誘導体
US8835444B2 (en) 2010-02-02 2014-09-16 Novartis Ag Cyclohexyl amide derivatives as CRF receptor antagonists
NZ732213A (en) 2014-10-24 2019-02-22 Landos Biopharma Inc Lanthionine synthetase c-like 2-based therapeutics
US11197891B2 (en) 2017-11-30 2021-12-14 Landos Biopharma, Inc. Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith
WO2021127472A1 (en) 2019-12-20 2021-06-24 Landos Biopharma, Inc. Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991064A (en) * 1975-01-17 1976-11-09 Warner-Lambert Company Benzonaphthyridines
US5576336A (en) * 1993-03-18 1996-11-19 Merck Sharp & Dohme Limited Indole derivatives as dopamine D4 antagonists
ATE171447T1 (de) * 1993-03-18 1998-10-15 Merck Sharp & Dohme Benzimidazole derivate
US5521297A (en) * 1993-06-04 1996-05-28 Salk Institute Biotechnology/Industrial Associates Nucleic acids encoding human metabotropic glutamate receptors
CA2188949A1 (en) * 1994-04-28 1995-11-09 Janusz Jozef Kulagowski Benzofuran derivatives as d4 receptor antagonists
ES2145289T3 (es) * 1994-08-10 2000-07-01 Merck Sharp & Dohme Derivados tetrahidropiridinilmetilo de pirrolo(2,3-b)piridina.
US5688798A (en) * 1995-10-10 1997-11-18 Hoffmann-La Roche Inc. Pyrimidine compounds
AUPR201600A0 (en) * 2000-12-11 2001-01-11 Fujisawa Pharmaceutical Co., Ltd. Quinazolinone derivative
GB0128996D0 (en) * 2001-12-04 2002-01-23 Novartis Ag Organic compounds
US6806279B2 (en) * 2001-12-17 2004-10-19 Sunesis Pharmaceuticals, Inc. Small-molecule inhibitors of interleukin-2
US6995144B2 (en) * 2002-03-14 2006-02-07 Eisai Co., Ltd. Nitrogen containing heterocyclic compounds and medicines containing the same
GB0503646D0 (en) * 2005-02-22 2005-03-30 Novartis Ag Organic compounds
GB0508318D0 (en) * 2005-04-25 2005-06-01 Novartis Ag Organic compounds
GB0508319D0 (en) * 2005-04-25 2005-06-01 Novartis Ag Organic compounds

Similar Documents

Publication Publication Date Title
JP2008538779A5 (cg-RX-API-DMAC7.html)
JP2008538775A5 (cg-RX-API-DMAC7.html)
JP6043935B2 (ja) ピペラジノトリアゾール化合物及びその製造方法と製薬用途
CN1938307B (zh) 9-取代的8-氧代腺嘌呤
JP6397488B2 (ja) RORγ調節因子
EP2253625B1 (en) Pyridazinones, the preparation and the use thereof
CN108727378A (zh) 新型异喹啉类化合物及其医药用途
JP2010505930A5 (cg-RX-API-DMAC7.html)
CN1496264A (zh) 4-氟-n-(1,2-二氢化茚-2-基)苯甲酰胺及其作为药物的用途
JP4660045B2 (ja) NF−κB阻害剤を有効成分とする心筋炎、拡張型心筋症および心不全の予防または治療薬
JP2022519237A (ja) Dnaポリメラーゼシータ阻害剤としてのアセトアミド誘導体
US20240287098A1 (en) Compositions and methods for treating cancer
WO2015083750A1 (ja) 神経新生に関する化合物及び医薬組成物
US20190092789A1 (en) Heterobicyclic pyrimidinone compounds and their use in the treatment of medical disorders
PT1877365E (pt) Derivados de acetileno
CN1268122A (zh) 用作nos抑制剂的支化烷氧基取代的2-氨基吡啶
JP2007518767A5 (cg-RX-API-DMAC7.html)
JP2014511865A (ja) 水溶液中で多量化できるシリル単量体、およびその使用法
JP6542236B2 (ja) 有機化合物
JPH11189586A (ja) キノリン誘導体、イソキノリン誘導体、およびシンノリン誘導体、並びに抗炎症剤および抗アレルギー剤
JP2005517634A5 (cg-RX-API-DMAC7.html)
JP2013532146A5 (cg-RX-API-DMAC7.html)
US20170369417A1 (en) TAK1 Kinase Inhibitors, Compositions, and Uses Related Thereto
JP2019504827A (ja) ポリヒドロキシ化ベンゾフェノンの組成物及び神経変性障害の処置方法
KR101965348B1 (ko) N'-히드록시인다졸카르복시이미다미드 유도체 화합물, 이의 광학이성질체, 또는 이의 약학적으로 허용가능한 염, 및, 이를 유효성분으로 포함하는 항암용 조성물